How much does online GLP-1 (semaglutide) treatment cost in Europe?

Short answer: Online GLP-1 (semaglutide) treatment in Europe typically costs €150–400 per month for the medication itself, plus €100–300 for an initial medical consultation and ongoing physician review. Total first-month cost ranges from €250–700; ongoing months cost €150–400. Prices vary by country, dosage, and whether you use a private telehealth platform or national health service, and some EU countries may offer partial reimbursement through insurance.

Who pays what: private telehealth vs. national systems

In the EU, GLP-1 access splits between private telehealth platforms (like AETHERA Health) and national health services. Private platforms charge transparent per-month fees because they operate outside state reimbursement systems. National health services (NHS in the UK, Sécurité Sociale in France, etc.) may cover semaglutide for type 2 diabetes or, increasingly, for weight management, but access is often restricted to specific criteria and waiting lists can be long. Private telehealth is faster and more accessible but requires out-of-pocket payment, though some patients have partial reimbursement through private insurance.

Breakdown: consultation, medication, and monitoring

A typical online GLP-1 pathway involves three cost components:

Initial consultation (€100–300). A licensed EU physician reviews your medical history, blood pressure, weight, and metabolic markers to confirm semaglutide is appropriate. This is non-negotiable: EU regulations require a physician assessment before any prescription.

Medication (€150–400/month). Semaglutide (Ozempic, Wegovy, or biosimilars) is supplied as a pre-filled pen or vial. Costs depend on starting dose (0.25 mg) and titration schedule. A 4-week supply at the lowest dose costs around €150–200; higher maintenance doses (0.5–1 mg weekly) cost €250–400. Biosimilar versions, now available in some EU countries, may be 10–20% cheaper than branded Ozempic or Wegovy.

Ongoing monitoring (€50–150 per visit). Most platforms require check-ins every 4–12 weeks to assess tolerability, adjust dose, and monitor for side effects. Some platforms bundle this into a monthly subscription; others charge per consultation.

Timeline and payment structure

Most private telehealth platforms operate on a monthly subscription or pay-per-visit model. AETHERA Health, for example, charges a consultation fee upfront, then a monthly medication fee; you pay only for the months you continue treatment. First delivery typically arrives within 5–10 working days of prescription. Some platforms offer quarterly or annual discounts if you commit upfront.

National health services are free or low-cost but involve longer waits (weeks to months) and stricter eligibility criteria, usually limited to BMI >30 with comorbidities or type 2 diabetes.

EU regulatory and cost context

Semaglutide is a GLP-1 receptor agonist approved across the EU for type 2 diabetes (Ozempic) and weight management (Wegovy). Prices are not centrally regulated; each country sets its own reference price, and private platforms set their own fees. Germany, France, and the Netherlands tend to have lower medication costs due to larger generic/biosimilar markets; smaller markets (Portugal, Greece) may be slightly higher. VAT (typically 17–23%) is included in quoted prices.

Biosimilar semaglutide (e.g., Rybelsus alternatives) is entering the market and may reduce costs by 15–30% within 2–3 years. Insurance reimbursement for weight management is expanding in countries like Germany and France, but private telehealth remains the fastest route to treatment.

Frequently asked questions

Is semaglutide covered by EU health insurance?

Coverage varies by country and insurer. Most national health services cover semaglutide for type 2 diabetes; weight management coverage is expanding but often requires BMI >35 or comorbidities. Private insurance rarely covers it. Check your policy or ask your provider.

Can I get semaglutide cheaper through a national health service?

Yes, if you qualify. NHS and European public systems charge little or nothing, but eligibility is strict and waiting lists are long (3–6 months). Private telehealth is faster and more flexible but costs more upfront.

Do I need to pay for every consultation, or is it included in the monthly fee?

It depends on the platform. Some charge a flat monthly subscription that includes consultations; others charge per visit. AETHERA Health includes physician review in its monthly fee structure, so you know the total cost upfront.

What happens if I stop treatment? Do I get a refund?

Most platforms operate on a month-to-month basis with no long-term contract, so you can stop anytime. Unused medication is not typically refunded, but you are not charged for future months once you cancel.

Are there cheaper alternatives to semaglutide?

Other GLP-1 agonists (tirzepatide, liraglutide) exist but are similarly priced or more expensive. Older weight-loss medications (phentermine, orlistat) are cheaper but less effective. Your physician will recommend the best option based on your health profile.

---

If you're considering GLP-1 treatment in the EU, a licensed telehealth consultation is the fastest way to understand your options and costs. Start your assessment with AETHERA Health.